The Latest in AML

FLT3 inhibitor approved for rel/ref AML in Japan

September 25, 2018

NGS can predict AML relapse after HSCT

September 21, 2018

Insights could change treatment, classification of MPAL

September 13, 2018

Prophylaxis reduces bacteremia in some kids

September 13, 2018

Hormonal contraceptives tied to leukemia in progeny

September 12, 2018

Cell population appears to drive relapse in AML

September 11, 2018

Team identifies potential immunotherapy target for AML

September 10, 2018

PLK1 inhibitor receives orphan designation for AML

August 31, 2018

EC approves product for high-risk AML

August 28, 2018

FDA grants fast track designation to CX-01 for AML

August 28, 2018

Regimen appears effective in elderly, unfit MDS/AML

August 25, 2018

Role of SES in childhood cancer survival disparities

August 21, 2018

Inhibitor receives orphan designation for AML

August 21, 2018

Access to care drives disparity between urban, rural cancer patients

August 20, 2018

Partial hold placed on trial of drug for AML, MDS

August 18, 2018